West Pharmaceutical Services Inc. (NYSE: WST) stock closed at 299.52 per share at the end of the most recent trading day (a 1.03% change compared to the prior day closing price) with a volume of 349.66K shares and market capitalization of 22.19B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 9200 people. West Pharmaceutical Services Inc. CEO is Eric Mark Green.

The one-year performance of West Pharmaceutical Services Inc. stock is -17.65%, while year-to-date (YTD) performance is -36.14%. WST stock has a five-year performance of 216.89%. Its 52-week range is between 275.89 and 475.35, which gives WST stock a 52-week price range ratio of 11.85%

West Pharmaceutical Services Inc. currently has a PE ratio of 33.60, a price-to-book (PB) ratio of 9.59, a price-to-sale (PS) ratio of 7.84, a price to cashflow ratio of 35.60, a PEG ratio of 2.32, a ROA of 23.27%, a ROC of 28.73% and a ROE of 33.77%. The company’s profit margin is 23.74%, its EBITDA margin is 31.00%, and its revenue ttm is $2.88 Billion , which makes it $38.89 revenue per share.

Of the last four earnings reports from West Pharmaceutical Services Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.19 for the next earnings report. West Pharmaceutical Services Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for West Pharmaceutical Services Inc. is Moderate Buy (1.8), with a target price of $380.25, which is +26.95% compared to the current price. The earnings rating for West Pharmaceutical Services Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

West Pharmaceutical Services Inc. has a dividend yield of 0.24% with a dividend per share of $0.72 and a payout ratio of 11.00%.

West Pharmaceutical Services Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.41, ATR14 : 9.22, CCI20 : -9.07, Chaikin Money Flow : -0.08, MACD : -4.43, Money Flow Index : 54.43, ROC : 2.05, RSI : 48.59, STOCH (14,3) : 66.15, STOCH RSI : 0.71, UO : 60.64, Williams %R : -33.85), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of West Pharmaceutical Services Inc. in the last 12-months were: Kimberly Banks MacKay (Option Excercise at a value of $114 430), Quintin J. Lai (Option Excercise at a value of $1 285 616), Quintin J. Lai (Sold 17 688 shares of value $7 435 942 )